OTLK icon

Outlook Therapeutics

64 hedge funds and large institutions have $62.7M invested in Outlook Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

21.77% less ownership

Funds ownership: 58.05%36.28% (-22%)

30% less capital invested

Capital invested by funds: $89.9M → $62.7M (-$27.2M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99K
Puts
$7K
Net Calls
Net Calls Change

Top Buyers

1 +$3.7M
2 +$1.84M
3 +$1.63M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.52M
5
BlackRock
BlackRock
New York
+$1.18M

Top Sellers

1 -$8.53M
2 -$1.87M
3 -$341K
4
Millennium Management
Millennium Management
New York
-$331K
5
Bank of America
Bank of America
North Carolina
-$327K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.6M
2
$12M
3
$4.9M
4
$4.22M
5
$4.04M
6
$3.7M
7
$3.69M
8
$3.32M
9
$2.11M
10
$1.84M
11
$1.82M
12
$1.69M
13
$1.56M
14
$1.11M
15
$616K
16
$352K
17
$339K
18
$306K
19
$303K
20
$266K
21
$245K
22
$243K
23
$232K
24
$150K
25
$116K